“In any case, we had to meet our customers’ requirements, especially in terms of traceability,” says Caroline Guérin. “Some of them, in the railway industry for example, have more and more regulatory constraints. They require advanced traceability in terms of precision, tracking, manufacturing, and repair. Many of them have the SNCF (France’s national state-owned railway company) as end customers, which has very specific standards,” she explains.
This is also true in the medical field, where the traceability of medical devices is a prerequisite. In January, OSE obtained its ISO 13485
certification for its quality management system, which requires the company to demonstrate its ability to regularly supply these devices. “Our MES enabled us, among other things, to obtain this certification,” says Caroline Guérin.
OSE’s managers understood very well the biggest stake: true traceability begins with the supply chain and ends with delivery to the customer. “This was an opportunity for our company to stand out from its competitors and to go even further, right to the heart of the map. Investment is in OSE DNA. Not investing means market losses, either in the present or in the future”, says Caroline Guérin.